JB Chemicals has received US FDA approval to market its generic version of Amitriptyline Hydrochloride tablets, used to treat ...

Doctors are warning that people taking certain antidepressants could be at risk of serious health problems as temperatures ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Finding the right antidepressant early in treatment may improve response rates, reduce time wasted on trial and error, and ...

Discover 8 surprising reasons why depression can worsen even while taking medication, including lifestyle factors and medical ...

Compass Pathways' psilocybin-based depression therapy reduced the severity of symptoms in a closely watched study, but shares of the biotech firm plunged more than 46% to a record low on Monday as the ...

JB Chemicals share price will reman in focus on June 25 following the company received USFDA approval for its Amitriptyline ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

A highly cited trial from 2007 used by international health agencies to support the use of medication for adolescents with ...

We’ve evolved in accepting mental health issues—the brain is an organ, just like any other—but mental health is still ...

Drugmaker Supernus Pharmaceuticals said on Monday it will acquire Sage Therapeutics , which makes treatments for neurological ...

The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...